{
  "id": 3248,
  "text": "Eur J Gynaecol Oncol 34, 527-531 (2013).1188.Ferrandina, G., et al.Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.Gynecol Oncol 128, 518-523 (2013).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Eur J Gynaecol Oncol 34, 527-531 (2013).1188.Ferrandina, G., et al.Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.Gynecol Oncol 128, 518-523 (2013).\n\n<question>: ",
  "ChatGPT_response_0": "常用的新辅助疗法是紫杉醇（paclitaxel）、表柔比星（epirubicin）和顺铂（cisplatin）这一药物组合。这种药物组合在治疗宫颈癌中作为新辅助治疗方案被广泛应用，并且在一些研究中显示出长期效果。紫杉醇、表柔比星和顺铂的组合被认为在局部晚期宫颈癌的治疗中具有潜在的疗效，但具体的治疗方案和效果仍需进一步的研究和临床实践来验证。",
  "query": " 在治疗宫颈癌方面，常用的新辅助疗法是哪种药物组合？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>:  在治疗宫颈癌方面，常用的新辅助疗法是哪种药物组合？\n\n<reference text>: Eur J Gynaecol Oncol 34, 527-531 (2013).1188.Ferrandina, G., et al.Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results.Gynecol Oncol 128, 518-523 (2013).\n\n<reply>: ",
  "response": "常用的新辅助疗法是紫杉醇（paclitaxel）、表柔比星（epirubicin）和顺铂（cisplatin）这一药物组合。这种药物组合在治疗宫颈癌中作为新辅助治疗方案被广泛应用，并且在一些研究中显示出长期效果。紫杉醇、表柔比星和顺铂的组合被认为在局部晚期宫颈癌的治疗中具有潜在的疗效，但具体的治疗方案和效果仍需进一步的研究和临床实践来验证。"
}